A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors
Clinical trial NCT04805060 · UNKNOWN
Trial details
- NCT number
- NCT04805060
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-23
- Primary completion
- 2021-12-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.